~ꢀ
A. Banon-Caballero et al. / Tetrahedron 69 (2013) 1307e1315
1313
(m, 1H), 2.50e2.61 (m, 2H), 4.07 (s, 1H), 4.84 (d, J¼8.4 Hz, 1H), 7.45
(d, J¼8.3 Hz, 2H), 7.65 (d, J¼8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3):
280 nm, (n-hexane/i-PrOH: 80/20, 1.0 mL/min), anti: tR¼19.021 (mi-
nor), tR¼22.454 (major), syn: tR¼13.727 (minor), tR¼15.700 (major).
d
24.6, 27.6, 30.6, 42.6, 57.0, 74.1, 111.6, 118.6, 127.7, 132.2, 146.3,
-
214.8; HPLC Chiralpak AD (n-hexane/i-PrOH: 95/05, 1.0 mL/min),
anti: tR¼44.854 (major), tR¼59.214 (minor), syn: tR¼29.828 (minor),
tR¼38.261 (major).
4.2.1.9. (S)-4-Hydroxy-(4-nitrophenyl)butan-2-one (6da).25
Yield (0.058 g, 93%) 1H NMR (300 MHz, CDCl3):
d 2.22 (s, 3H),
2.86 (d, J¼1.8 Hz,1H), 2.88 (s,1H) 3.70 (s,1H), 5.27 (dd, J¼2.9, 3.3 Hz,
1H), 7.54 (d, J¼8.8 Hz, 2H), 8.21 (d, J¼8.8 Hz, 2H); 13C NMR (75 MHz,
4.2.1.3. (R)-2-((S)-Hydroxy(phenyl)methyl)cyclohexanone (anti-
CDCl3): d 30.6, 51.4, 68.8, 123.7, 126.3, 147.3, 149.9, 208.2; HPLC
6ac).26 Yield (0.052 g, 85%) 1H NMR (300 MHz, CDCl3):
d
1.27e1.36
Chiralpak AS-H column at 280 nm, (n-hexane/i-PrOH: 85/15,1.0 mL/
min), tR¼25.755 (minor), tR¼34.741 (major).
(m, 1H), 1.50e1.80 (m, 4H), 2.04e2.12 (m, 1H), 2.30e2.42 (m, 1H),
2.43e2.54 (m, 1H), 2.58e2.67 (m, 1H), 4.05 (br s, 1H), 4.78 (d,
J¼8.9 Hz, 1H), 7.29e7.37 (m, 5H); 13C NMR (75 MHz, CDCl3):
d
24.7,
4.2.1.10. (S)-1-Hydroxy-1-(4-nitrophenyl)pentan-3-one (7ea).25
-
27.8, 30.8, 42.6, 57.4, 74.7, 127.0, 127.9, 128.3, 140.8, 215.5; HPLC
Chiralcel OD-H column at 210 nm, (n-hexane/i-PrOH: 95/5, 0.5 mL/
min), anti: tR¼23.507 (minor), tR¼31.015 (mayor), syn: tR¼18.107
(mayor), tR¼20.340 (minor).
Yield (0.045 g, 67%) 1H NMR (300 MHz, CDCl3):
d
1.09 (t, J¼7.3 Hz,
3H), 2.48 (q, J¼7.3 Hz, 2H), 2.82 (m, 2H), 3.67 (d, J¼3.3 Hz, 1H), 5.27
(dt, J¼3.5 Hz, 7.7,1H), 7.53 (d, J¼8.6 Hz, 2H), 8.21 (d, J¼9.8 Hz, 2H); 13
C
NMR (75 MHz, CDCl3): d 7.4, 36.8, 50.2, 69.1, 123.7, 126.4, 147.3, 150.1,
211.4; HPLC Chiralpak AS-H column at 280 nm, (n-hexane/i-PrOH:
95/05, 1.0 mL/min), tR¼63.672 (minor), tR¼125.772 (major).
4.2.1.4. (R)-2-((S)-Hydroxy(2-nitrophenyl)methyl)cyclohexanone
(anti-6ad).27 Yield (0.064 g, 86%) 1H NMR (300 MHz, CDCl3):
d
1.27e1.36 (m,1H),1.50e1.80 (m, 4H), 2.04e2.12 (m,1H), 2.30e2.42
4.2.1.11. (3R,4R)-4-Hydroxy-3-methoxy-4-(4-nitrophenyl)butan-
(m,1H), 2.43e2.54 (m,1H), 2.58e2.67 (m,1H), 4.05 (br s,1H), 4.78 (d,
2-one (anti-6fa).29 Yield (0.066 g, 92%) 1H NMR (300 MHz, CDCl3):
d
J¼8.9 Hz, 1H), 7.29e7.37 (m, 5H); 13C NMR (75 MHz, CDCl3):
d
24.7,
2.16 (s, 3H), 3.32 (s, 3H), 3.70 (d, J¼6.2 Hz,1H), 5.02 (d, J¼6.2 Hz,1H),
27.8, 30.8, 42.6, 57.4, 74.7, 127.0, 127.9, 128.3, 140.8, 215.5; HPLC
Chiralpak AD column at 280 nm, (n-hexane/i-PrOH: 95/05, 0.7 mL/
min), anti: tR¼45.038 (minor), tR¼47.244 (major), syn: tR¼32.131
(minor), tR¼33.738 (major).
7.56 (d, J¼8.8 Hz, 2H), 8.22 (d, J¼8.8 Hz, 2H); 13C NMR (75 MHz,
CDCl3):
d 27.5, 59.6, 73.3, 89.6, 123.4, 127.7, 146.7, 147.7, 209.9; HPLC
Chiralcel OD-H column at 280 nm, (n-hexane/i-PrOH: 90/10, 0.7 mL/
min), anti: tR¼17.047 (minor), tR¼18.578 (major), syn tR¼21.181
(major), tR¼25.327 (minor).
4.2.1.5. (R)-2-((S)-Hydroxy(3-nitrophenyl)methyl)cyclohexanone
4.2.1.11.1. (R)-4-Hydroxy-1-(methylthio)-4-(4-nitrophenyl)butan-
(anti-6ae).27 Yield (0.067 g, 90%) 1H NMR (300 MHz, CDCl3):
2-one (7ga).29 Yield (0.037 g, 48%) 1H NMR (300 MHz, CDCl3):
d 2.06
d
1.55e1.87 (m, 5H), 2.04e2.17 (m, 1H), 2.28e2.49 (m, 2H),
(s, 3H), 3.06 (d, J¼6.2 Hz, 2H), 3.19 (s, 2H), 5.29 (t, J¼6.1 Hz, 1H), 7.57
2.71e2.80 (m, 1H), 4.19 (br s, 1H), 5.45 (d, J¼7.2 Hz, 1H), 7.40e7.46
(d, J¼8.5 Hz, 2H), 8.22 (d, J¼8.8 Hz, 2H);13C NMR (75 MHz, CDCl3):
(m, 1H), 7.61e7.66 (m, 1H), 7.73e7.80 (m, 1H), 7.82e7.88 (m, 1H);
d
15.6, 43.3, 48.0, 69.3, 123.7, 126.7, 147.4, 149.8, 204.7; HPLC Chir-
13C NMR (75 MHz, CDCl3):
d
24.9, 27.7, 31.0, 42.8, 57.2, 69.7, 124.0,
alcel OD-H column at 280 nm, (n-hexane/i-PrOH: 95/05, 1.0 mL/
min), tR¼42.461 (major), tR¼47.734 (minor).
128.3, 128.9, 133.0, 136.5, 148.6, 214.9; HPLC Chiralpak AD column
at 254 nm, (n-hexane/i-PrOH: 95/05, 0.7 mL/min), anti: tR¼50.356
(minor), tR¼64.643 (major), syn: tR¼39.063 (minor), tR¼44.716
(major).
4.2.2. General procedure for the aldol reaction between aldehydes
catalyzed by 3. To a mixture of the corresponding aromatic aldehyde
(0.3 mmol), catalyst 3 (0.06 mmol, 200 mg) and benzoic acid
(0.015 mmol, 2 mg) at 25 ꢀC was added the propanal (1.5 mmol,
4.2.1.6. (R)-2-((S)-Hydroxy-(3-methylphenyl)methyl)cyclohexa-
none (anti-6af).28 Yield (0.053 g, 82%) 1H NMR (300 MHz, CDCl3):
110 mL) and H2O (64 mL). The reaction was stirred until the aldehyde
d
1.24e1.32 (m, 1H), 1.52e1.70 (m, 3H), 1.73e1.83 (m, 1H), 2.03e2.13
was consumed (monitored by TLC). Then, the mixture was filtered
and washed with 10e15 mL of EtOAc. The solvents were removed
under reduced pressure and the residue was diluted with MeOH
(1 mL) then NaBH4 (0.3 mmol, 12 mg) was added at 0 ꢀC, and the
mixturewasstirredfor 1 h. The resultingresiduewaspurified by flash
chromatography (hexanes/EtOAc; 4/1) to yield the pure product.
(m,1H), 2.30e2.40 (m,1H), 2.35 (s, 3H), 2.45e2.53 (m,1H), 2.57e2.67
(m, 1H), 4.75 (d, J¼8.8 Hz, 1H), 7.07e7.12 (m, 2H), 7.15 (s, 1H), 7.22 (t,
J¼7.5 Hz, 1H); 13C NMR (75 MHz, CDCl3): 13C NMR (75 MHz, CDCl3)
d
21.4, 24.1, 27.8, 30.9, 42.7, 57.3, 74.7, 124.2, 127.6, 128.2, 128.6, 138.1,
140.8, 215.7; HPLC Chiralcel OD-H column at 210 nm, (n-hexane/i-
PrOH: 95/05,1.0mL/min), anti: tR¼10.783 (minor), tR¼13.176 (major).
4.2.2.1. (1S,2S)-2-Methyl-1-(4-nitrophenyl)propane-1,3-diol
4.2.1.7. (R)-2-((R)-Hydroxy(4-nitrophenyl)methyl)cyclo-
(anti-8a).10f Yield (0.047 g, 75%) 1H NMR (300 MHz, CDCl3):
d 0.78
pentanone (anti-6ba).29 Yield (0.056 g, 80%) 1H NMR (300 MHz,
CDCl3): d 1.72e1.75 (m, 2H), 1.90e2.55 (m, 5H), 2.95 (s,1H, syn), 4.77
(d, J¼7.0 Hz, 3H), 2.01e2.06 (m, 1H), 2.74 (br s, 1H), 3.72e3.85 (m,
3H), 4.72 (d, J¼7.8 Hz, 1H anti), 7.54 (d, J¼8.7 Hz, 2H), 8.23 (d,
(s, 1H, anti), 4.84 (d, J¼9.1 Hz, 1H, anti), 5.42 (s, 1H, syn), 7.52 (d,
J¼8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d 13.6, 41.5, 67.4, 79.3,
123.6, 127.5, 147.4, 150.5; HPLC Chiralpak AD, (hexanes/i-PrOH: 96/
04, 0.9 mL/min), tR¼72.965 (minor), tR¼74.885 (mayor).
J¼8.4 Hz, 2H), 8.21 (d, J¼8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d
syn
20.2, 22.2, 38.8, 56.0, 70.3, 123.6, 126.3, 147.0, 150.2, 219.6; anti 20.2,
26.7, 38.5, 55.0, 74.3, 123.5, 127.3, 147.2, 148.5, 222.8; HPLC Chiralpak
AD column at 280 nm, (n-hexane/i-PrOH: 97/03, 1.0 mL/min), anti:
tR¼75.661 (minor), tR¼83.634 (major), syn: tR¼43.228 (minor),
tR¼65.514 (major).
4.2.2.2. 4-((1S,2S)-1,3-Dihydroxy-2-methylpropyl)benzoni-
trile(anti-8b).30 Yield (0.040 g, 70%) 1H NMR (300 MHz, CDCl3):
d
0.75 (d, J¼7.0 Hz, 3H), 1.94e2.10 (m, 1H), 3.64e3.74 (m, 1H),
3.76e3.84 (m, 1H), 4.64 (d, J¼7.8 Hz, 1H anti), 7.47 (d, J¼8.1 Hz, 2H),
4.2.1.8. (R)-3-((S)-Hydroxy(4-nitrophenyl)methyl)dihydro-2H-
7.65 (d, J¼8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d 13.7, 41.4, 67.5,
pyran-4(3H)-one (anti-6ca).27 Yield (0.072 g, 95%) 1H NMR
(300 MHz, CDCl3): d 2.50e2.60 (m,1H), 2.63e2.73 (m,1H), 2.85e2.93
79.7, 111.4, 118.8, 127.4, 132.2, 148.7; HPLC with a Chiralpak AD col-
umn at 230 nm, (n-hexane/i-PrOH: 95/05, 1.0 mL/min), tR¼41.956
(minor), tR¼43.957 (mayor).
(m, 1H), 3.46 (dd, J¼11.4, 9.6 Hz, 1H), 3.73e3.81 (m, 2H), 3.9 (s, 1H),
4.16e4.27 (m, 1H), 5.00 (d, J¼9.8 Hz, 1H), 7.52 (d, J¼8.7 Hz, 2H), 8.23
(d, J¼8.8 Hz, 1H); 13C NMR (75 MHz, CDCl3):
d
42.7, 57.5, 68.2, 69.7,
4.2.3. General procedure for the aldol intramolecular reaction cata-
lyzed by ent-3. To the catalyst ent-3 (0.06 mmol, 200 mg) and
71.2, 123.8, 127.4, 147.4, 147.7, 209.1; HPLC Chiralpak AD-H column at